Sunday, August 16, 2026 Never miss a recall or a rule change Go Pro · $20/mo →
Inside MedSpa
FDA Recall & Compliance Alerts for Medspa Owners
InjectablesHugel Posts Record H1 on Toxin Surge—Overseas Growth AcceleratestodayMarketHugel Posts Record H1 Revenue on Overseas Toxin Surge3 days agoDevices & TechApyx: GLP-1 Boom Is Fueling Renuvion DemandtodayMarketMedytox Q2 Sales Up 11%, Operating Profit Down 25%3 days agoInjectablesGalderma Wins EU Nod for Restylane ShaypeyesterdayBusiness & M&AEstablishment Labs Raises 2026 Revenue Guidance2 days agoDevices & TechMerz Ultherapy PRIME Clears FDA for Knee Skin LaxityyesterdayBusiness & M&ABeauty Health Q2 Earnings: Device Demand Steady2 days agoInjectablesHugel Debuts Thechaum Signature with Reduced CrosslinkeryesterdayDevices & TechAlma Launches TitaniumLift™ Multi-Depth RF Protocol2 days agoInjectablesGLP-1 Boom Exposed Filler Limitations—Here's WhyyesterdayInjectablesGalderma Chief: Start GLP-1 Patients on Skin Care First2 days ago
Sector Catalysts

IRA Tax Credits

Inflation Reduction Act clean-energy credits like 45Q and 45X that subsidize domestic energy manufacturing.

Also known as: 45Q, 45X, Clean Energy Credits

What it is
The Inflation Reduction Act created a suite of clean-energy tax credits, including 45Q for carbon capture and 45X for domestic manufacturing of components like solar cells and batteries. They subsidize production and investment. Treasury guidance defines eligibility.
What it does
These credits improve project economics and manufacturing margins for solar, wind, battery, and carbon-capture players, shaping capacity decisions. Guidance releases and eligibility rulings are catalysts. Policy risk cuts both ways as credits can be revised.
The evidence
45X manufacturing credits have bolstered margins for domestic solar and battery component makers, supporting reshoring plans.
Best for
Clean-energy names: FSLR, ENPH, NEE; ETFs TAN, ICLN.
Pairs well with
reconciliation, chips-act, spr
Use cautiously with
Credits are politically vulnerable and subject to guidance details; assuming they are permanent ignores repeal and phase-out risk.
Cautions
Treasury guidance can narrow eligibility, changing which firms actually qualify.
General information, not medical advice. Ingredient effects vary by formulation, concentration, and skin. Patch-test new actives and consult a qualified provider before starting prescription ingredients.

Know what's coming before your patients ask for it.

New actives, device launches, and the FDA calls that change what you can offer — distilled into a two-minute brief, twice a week. Inside MedSpa Pro.

Go Pro · $20/mo
Inside MedSpa Pro

By the time it's news, it's too late.

The rebate cut, the scope-of-practice bill, the competitor opening down the street — it hits your business before the trade press ever covers it. Pro gets you there first: what happened, why it touches your margins, and exactly what to do — at 6 AM, in two minutes.

Go Pro · $20/mo Never miss a recall or a rule change. Cancel anytime.
The twice-a-week intelligence brief Go Pro · $20/mo